Avantor, Inc.

Avantor, Inc.

AVTRยทNYSE

$9.07

+2.1%
HealthcareMedical - Instruments & Supplies

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$6.19B
EPS-0.7800
P/E Ratio-11.63
Earnings Date08/07/2026
3Y-12.0%
5Y+19.0%
10Y+938.0%
3Y-28.0%
5Y-14.0%
10Y+278.0%
3Y+15.0%
5Y+108.0%
10Y-1190.0%
avtr

Avantor, Inc. Funding & Solvency Profile

AVTR ยท NYSE
Cash & Cash Equivalents365.40M
Net Receivables1.07B
Inventory818.20M
Other Current Assets193.00M
Total Current Assets2 B
Property, Plant & Equipment766.80M
Goodwill & Intangible Assets8.18B
Long-Term Investments0.00
Other Non-Current Assets396.00M
Total Non-Current Assets1 B
Total Assets
11.79B

Financial Health Analysis

Current Ratio

1.78x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.12x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

1 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

21% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Avantor, Inc. Balance Sheet

AVTR โ€ข NYSE

Avantor, Inc. Balance SheetDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
ASSETS
CURRENT ASSETS
365.4M
261.9M
262.9M
372.9M
301.7M
286.6M
186.7M
184.7M
185.4M
62.9M
365.4M
261.9M
262.9M
372.9M
301.7M
286.6M
186.7M
184.7M
185.4M
62.9M
1.1B
1B
1.2B
1.2B
1.2B
1.1B
988.8M
931.2M
875M
87.9M
1.1B
1B
1.2B
1.2B
1.2B
1.1B
988.8M
931.2M
875M
87.9M
818.2M
731.5M
828.1M
913.5M
872M
739.6M
711.2M
671.1M
695.1M
122.2M
193M
118.7M
143.7M
153.1M
81.4M
91.4M
134.8M
112.6M
78.3M
19M
2.5B
2.1B
2.4B
2.7B
2.5B
2.2B
2B
1.9B
1.8B
292M
NON-CURRENT ASSETS
766.8M
708.1M
737.5M
727M
705.5M
549.9M
557M
598.6M
663.5M
204M
5B
5.5B
5.7B
5.7B
5.3B
2.9B
2.8B
2.8B
2.8B
186.1M
3.2B
3.4B
3.8B
4.1B
5.1B
4B
4.2B
4.6B
5B
441.4M
8.2B
8.9B
9.5B
9.8B
10.5B
6.9B
7B
7.4B
7.8B
627.5M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.1M
396M
360.4M
358.3M
293.5M
233.1M
216.7M
205.2M
63M
112.6M
9.2M
9.3B
10B
10.6B
10.8B
11.4B
7.7B
7.8B
8B
8.6B
843.8M
0.0
300K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
11.8B
12.1B
13B
13.5B
13.9B
9.9B
9.8B
9.9B
10.4B
1.1B
LIABILITIES
CURRENT LIABILITIES
741.7M
662.8M
625.9M
758.2M
755.1M
678.9M
560.2M
557.4M
542M
58M
741.7M
662.8M
625.9M
758.2M
755.1M
678.9M
560.2M
557.4M
542M
48M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10M
47.3M
48.6M
50.2M
49.9M
49.8M
44.5M
74.2M
76.6M
79M
0.0
30.8M
821.1M
259.9M
364.2M
45.2M
26.4M
93.5M
142.4M
109M
13.7M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
7M
10M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
10M
559.1M
475M
544.3M
486.5M
600.7M
492.9M
346.6M
319.8M
374.3M
64.2M
1.4B
2B
1.5B
1.7B
1.5B
1.2B
1.1B
1.1B
1.1B
135.9M
NON-CURRENT LIABILITIES
3.9B
3.2B
5.3B
5.9B
7B
4.9B
5B
6.8B
7B
1.3B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.9B
3.6B
0.0
557.1M
557.3M
612.8M
731.4M
913M
723.9M
785.4M
907.5M
1.1B
0.0
378.2M
358.3M
350.3M
295.4M
358.4M
398.1M
428.2M
4.2B
3.9B
228.1M
4.9B
4.2B
6.2B
7B
8.2B
6B
6.2B
11.9B
12B
1.5B
0.0
0.0
0.0
0.0
0.0
0.0
163M
66.3M
0.0
0.0
6.2B
6.2B
7.7B
8.6B
9.7B
7.2B
7.3B
13B
13.1B
1.6B
SHAREHOLDERS' EQUITY
-75.7M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1B
1B
1B
3.9B
3.6B
338.8M
4B
3.9B
3.8B
3.8B
2.8B
1.7B
1.7B
0.0
0.0
0.0
1.7B
2.2B
1.5B
1.2B
483.9M
-88.7M
-203.7M
-238.4M
-156.3M
-5.7M
-16.9M
-184M
-69M
-100.3M
-43.2M
21.7M
-85.9M
-66.5M
26.4M
-30.4M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-6.6B
-6.1B
-677.6M
5.6B
6B
5.3B
4.9B
4.2B
2.7B
2.5B
-3.1B
-2.6B
-374.9M
5.6B
6B
5.3B
4.9B
4.2B
2.7B
2.5B
-3.1B
-2.6B
-510.6M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-135.7M
SUMMARY
11.8B
12.1B
13B
13.5B
13.9B
9.9B
9.8B
9.9B
10.4B
1.1B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.1M
3.9B
4.1B
5.5B
6.3B
7B
4.9B
5.1B
6.9B
7.1B
1.3B
3.6B
3.8B
5.3B
5.9B
6.7B
4.6B
4.9B
6.7B
6.9B
1.2B
681,814,859
681,814,859
681,814,859
681,814,859
681,814,859
681,814,859
681,814,859
681,814,859
681,814,859
681,814,859

SEC Filings

AVTR - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 12, 2026
May 07, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 29, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 29, 2026
April 29, 2026
2026
8-K

8-K 2026

N/A

April 23, 2026
April 17, 2026
2026
8-K

8-K 2026

N/A

April 01, 2026
March 26, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 27, 2026
May 07, 2026
2026
8-K/A

8-K/A 2025 (Amended)

N/A

February 25, 2026
December 17, 2025
2025
8-K/A

8-K/A 2025 (Amended)

N/A

February 25, 2026
December 04, 2025
2025
8-K

8-K 2026

N/A

February 11, 2026
February 11, 2026
2026
10-K

10-K 2025 FY

FY

February 11, 2026
December 31, 2025
2025
Showing 1 to 10 of 144 filings